Blood, CSF Marker Detects Parkinsonian Disorders

(MedPage Today) -- A novel blood and cerebrospinal fluid (CSF) measure showed promise as a biomarker for Parkinsonian disorders. CSF levels of DOPA decarboxylase (DDC) -- an enzyme that converts levodopa into dopamine -- accurately identified...
Source: MedPage Today Neurology - Category: Neurology Source Type: news